Review paper
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Abstract
Importance
Autologous hematopoietic stem cell transplant (AHSCT) for multiple sclerosis has gained increasing interest in recent years. Despite the availability of many US Food and Drug Administration–approved disease-modifying therapies, some patients do not respond adequately and others may have very early aggressive disease that prompts consideration of alternative, highly effective, long-lasting therapy. The National Medical...Paper Details
Title
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Published Date
Oct 26, 2020
Journal
Volume
78
Issue
2
Pages
241 - 241